Health and Healthcare

Sangamo Therapeutics : SGMO

All Sangamo Therapeutics Articles

34 Articles

Jon C. Ogg | May 31, 2017 at 8:55 AM EDT

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.

Chris Lange | May 11, 2017 at 10:30 AM EDT

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.

Jon C. Ogg | Nov 1, 2016 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades for Tuesday: Baker Hughes, Brocade, CenturyLink, Chevron, Juniper, National Oilwell Varco and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Baker Hughes, Brocade Communications, CenturyLink, Chevron, Juniper Networks…

Jon C. Ogg | Aug 4, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apollo Global, ADM, Celgene, Total, Whole Foods and…

Chris Lange | Apr 6, 2016 at 11:05 AM EDT

Why Sangamo Shares Could More Than Double

Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs…

Jon C. Ogg | Jan 12, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CA, CarMax, Dean Foods, Freeport-McMoRan, Newmont, Shire, Wells Fargo and Many More

Stocks tried to stabilize on Monday, and Tuesday’s early indications were for Dow and S&P 500 futures to be up…

Jon C. Ogg | Dec 20, 2015 at 10:15 AM EST

14 Fresh Analyst Stocks Called to Rise 50% to 100%

These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks,…

Jon C. Ogg | Dec 17, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, CVS, Micron, Nike, Oracle, Pandora, Sunrun, US Steel and Many More

Thursday’s top analyst upgrades, downgrades and initiations include AK Steel, CVS Health, Micron Technology, Nike, Oracle, Pandora Media, Sunrun and…

Jon C. Ogg | Apr 4, 2013 at 6:56 AM EDT

Nineteen Stocks Expected to Rise 50% to 100% — or More

Investors and traders alike always seem to be on the lookout for new investment ideas. With the S&P 500 and the…

Jon C. Ogg | Mar 8, 2012 at 3:30 PM EST

Sangamo Presents Functional Cure For HIV/AIDS (SGMO)

Sangamo BioSciences, Inc. (NASDAQ: SGMO) has ticked higher on its report demonstrating that new clinical data is demonstrating persistent positive effects…

Jon C. Ogg | Feb 23, 2012 at 9:05 AM EST

Sangamo Files To Raise Capital (SGMO)

SANGAMO BIOSCIENCES, INC. (NASDAQ: SGMO) has filed to raise capital. The company filed with the SEC on Wednesday night to raise…

Paul Ausick | Feb 1, 2012 at 4:04 PM EST

24/7 Wall St. Closing Bell (C, NEM, STX, XOM, MWW, AMZN, BRCM, AET, COCO, EPD, MAN, MPC, NOC, WHR, KTCC, SGMO, MDVN, JDAS, IXYS)

The three major US stock indexes opened higher this morning, following on a positive debt sale by Portugal and some…

Douglas A. McIntyre | Oct 3, 2011 at 8:55 AM EDT

Top Active Trader Alert Stocks (ALU, LCC, SGMO, YHOO)

Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves…

Jon C. Ogg | May 2, 2011 at 7:46 PM EDT

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ:…

Douglas A. McIntyre | Oct 7, 2009 at 11:09 AM EDT

Major Secondary Offerings Keep Coming (ALTH, ATAX, ARYX, APPY, GRS, LINE, SGMO, CAR)

We are seeing more and more waves of secondary offerings continue to hit the Street since the stock market has…

1 2 3

Sangamo Therapeutics : SGMO

All Sangamo Therapeutics Articles

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Why Sangamo Therapeutics Is Surging

Top Analyst Upgrades and Downgrades for Tuesday: Baker Hughes, Brocade, CenturyLink, Chevron, Juniper, National Oilwell Varco and Many More

Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More

Why Sangamo Shares Could More Than Double

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CA, CarMax, Dean Foods, Freeport-McMoRan, Newmont, Shire, Wells Fargo and Many More

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: AK Steel, CVS, Micron, Nike, Oracle, Pandora, Sunrun, US Steel and Many More

Nineteen Stocks Expected to Rise 50% to 100% — or More

Sangamo Presents Functional Cure For HIV/AIDS (SGMO)

Sangamo Files To Raise Capital (SGMO)

24/7 Wall St. Closing Bell (C, NEM, STX, XOM, MWW, AMZN, BRCM, AET, COCO, EPD, MAN, MPC, NOC, WHR, KTCC, SGMO, MDVN, JDAS, IXYS)

Top Active Trader Alert Stocks (ALU, LCC, SGMO, YHOO)

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Major Secondary Offerings Keep Coming (ALTH, ATAX, ARYX, APPY, GRS, LINE, SGMO, CAR)

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Sangamo Therapeutics : SGMO

All Sangamo Therapeutics Articles

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Why Sangamo Therapeutics Is Surging

Top Analyst Upgrades and Downgrades for Tuesday: Baker Hughes, Brocade, CenturyLink, Chevron, Juniper, National Oilwell Varco and Many More

Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More

Why Sangamo Shares Could More Than Double

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CA, CarMax, Dean Foods, Freeport-McMoRan, Newmont, Shire, Wells Fargo and Many More

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: AK Steel, CVS, Micron, Nike, Oracle, Pandora, Sunrun, US Steel and Many More

Nineteen Stocks Expected to Rise 50% to 100% — or More

Sangamo Presents Functional Cure For HIV/AIDS (SGMO)

Sangamo Files To Raise Capital (SGMO)

24/7 Wall St. Closing Bell (C, NEM, STX, XOM, MWW, AMZN, BRCM, AET, COCO, EPD, MAN, MPC, NOC, WHR, KTCC, SGMO, MDVN, JDAS, IXYS)

Top Active Trader Alert Stocks (ALU, LCC, SGMO, YHOO)

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Major Secondary Offerings Keep Coming (ALTH, ATAX, ARYX, APPY, GRS, LINE, SGMO, CAR)

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s